The Global Covid-19 Vaccine Market Report is equipped with market data from 2015 to 2025. The report gives a covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2020 to 2025. The detailed sales channel is also covered in the study.
The global Covid-19 Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Covid-19 Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Covid-19 Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Covid-19 Vaccine market has been segmented into:
Table of Contents
1 Covid-19 Vaccine Market Overview
1.1 Product Overview and Scope of Covid-19 Vaccine
1.2 Classification of Covid-19 Vaccine by Type
1.2.1 Global Covid-19 Vaccine Revenue by Type
1.2.2 Global Covid-19 Vaccine Revenue Market Share by Type in 2019
1.2.3 DNA
1.2.4 Live Attenuated Virus
1.2.5 NonReplicating Viral Vecto
1.2.6 Protein Subunit
1.2.7 RNA
1.3 Global Covid-19 Vaccine Market by Application
1.3.1 Overview: Global Covid-19 Vaccine Revenue by Application
1.3.2 Treatment
1.3.3 Prevention
1.4 Global Covid-19 Vaccine Market by Regions
1.4.1 Global Covid-19 Vaccine Market Size by Regions
1.4.2 Global Market Size of Covid-19 Vaccine (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Covid-19 Vaccine Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Covid-19 Vaccine Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Covid-19 Vaccine Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Covid-19 Vaccine Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Covid-19 Vaccine Status and Prospect (2015-2025)
2 Company Profiles
2.1 Inovio Pharmaceuticals
2.1.1 Inovio Pharmaceuticals Details
2.1.2 Inovio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Inovio Pharmaceuticals SWOT Analysis
2.1.4 Inovio Pharmaceuticals Product and Services
2.1.5 Inovio Pharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.2 Altimmune
2.2.1 Altimmune Details
2.2.2 Altimmune Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Altimmune SWOT Analysis
2.2.4 Altimmune Product and Services
2.2.5 Altimmune Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.3 Codagenix, Inc.
2.3.1 Codagenix, Inc. Details
2.3.2 Codagenix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Codagenix, Inc. SWOT Analysis
2.3.4 Codagenix, Inc. Product and Services
2.3.5 Codagenix, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.4 Takis Biotech (Evvivax)
2.4.1 Takis Biotech (Evvivax) Details
2.4.2 Takis Biotech (Evvivax) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Takis Biotech (Evvivax) SWOT Analysis
2.4.4 Takis Biotech (Evvivax) Product and Services
2.4.5 Takis Biotech (Evvivax) Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.5 Janssen Pharmaceutical Companies
2.5.1 Janssen Pharmaceutical Companies Details
2.5.2 Janssen Pharmaceutical Companies Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Janssen Pharmaceutical Companies SWOT Analysis
2.5.4 Janssen Pharmaceutical Companies Product and Services
2.5.5 Janssen Pharmaceutical Companies Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.6 Zydus Cadila
2.6.1 Zydus Cadila Details
2.6.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Zydus Cadila SWOT Analysis
2.6.4 Zydus Cadila Product and Services
2.6.5 Zydus Cadila Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.7 CanSino Biologics
2.7.1 CanSino Biologics Details
2.7.2 CanSino Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 CanSino Biologics SWOT Analysis
2.7.4 CanSino Biologics Product and Services
2.7.5 CanSino Biologics Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bravovax
2.8.1 Bravovax Details
2.8.2 Bravovax Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bravovax SWOT Analysis
2.8.4 Bravovax Product and Services
2.8.5 Bravovax Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.9 GeoVax, Inc.
2.9.1 GeoVax, Inc. Details
2.9.2 GeoVax, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GeoVax, Inc. SWOT Analysis
2.9.4 GeoVax, Inc. Product and Services
2.9.5 GeoVax, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.10 Vaxart
2.10.1 Vaxart Details
2.10.2 Vaxart Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Vaxart SWOT Analysis
2.10.4 Vaxart Product and Services
2.10.5 Vaxart Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.11 Generex
2.11.1 Generex Details
2.11.2 Generex Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Generex SWOT Analysis
2.11.4 Generex Product and Services
2.11.5 Generex Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.12 Baylor
2.12.1 Baylor Details
2.12.2 Baylor Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Baylor SWOT Analysis
2.12.4 Baylor Product and Services
2.12.5 Baylor Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.13 ExpreS2ion Biotechnologies ApS
2.13.1 ExpreS2ion Biotechnologies ApS Details
2.13.2 ExpreS2ion Biotechnologies ApS Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 ExpreS2ion Biotechnologies ApS SWOT Analysis
2.13.4 ExpreS2ion Biotechnologies ApS Product and Services
2.13.5 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.14 Zydus Cadila
2.14.1 Zydus Cadila Details
2.14.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Zydus Cadila SWOT Analysis
2.14.4 Zydus Cadila Product and Services
2.14.5 Zydus Cadila Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.15 Novavax, Inc.
2.15.1 Novavax, Inc. Details
2.15.2 Novavax, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Novavax, Inc. SWOT Analysis
2.15.4 Novavax, Inc. Product and Services
2.15.5 Novavax, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.16 Vaxil Bio Ltd.
2.16.1 Vaxil Bio Ltd. Details
2.16.2 Vaxil Bio Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Vaxil Bio Ltd. SWOT Analysis
2.16.4 Vaxil Bio Ltd. Product and Services
2.16.5 Vaxil Bio Ltd. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.17 Clover Biopharmaceuticals
2.17.1 Clover Biopharmaceuticals Details
2.17.2 Clover Biopharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Clover Biopharmaceuticals SWOT Analysis
2.17.4 Clover Biopharmaceuticals Product and Services
2.17.5 Clover Biopharmaceuticals Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.18 iBio, Inc.
2.18.1 iBio, Inc. Details
2.18.2 iBio, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 iBio, Inc. SWOT Analysis
2.18.4 iBio, Inc. Product and Services
2.18.3 iBio, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.19 Sanofi Pasteur
2.19.1 Sanofi Pasteur Details
2.19.2 Sanofi Pasteur Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Sanofi Pasteur SWOT Analysis
2.19.4 Sanofi Pasteur Product and Services
2.19.5 Sanofi Pasteur Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.20 GSK
2.20.1 GSK Details
2.20.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 GSK SWOT Analysis
2.20.4 GSK Product and Services
2.20.5 GSK Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.21 Moderna, Inc.
2.21.1 Moderna, Inc. Details
2.21.2 Moderna, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Moderna, Inc. SWOT Analysis
2.21.4 Moderna, Inc. Product and Services
2.21.5 Moderna, Inc. Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.22 Curevac
2.22.1 Curevac Details
2.22.2 Curevac Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Curevac SWOT Analysis
2.22.4 Curevac Product and Services
2.22.5 Curevac Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
2.23 ImmunoPrecise
2.23.1 ImmunoPrecise Details
2.23.2 ImmunoPrecise Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 ImmunoPrecise SWOT Analysis
2.23.4 ImmunoPrecise Product and Services
2.23.5 ImmunoPrecise Covid-19 Vaccine Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Covid-19 Vaccine Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Covid-19 Vaccine Players Market Share
3.2.2 Top 10 Covid-19 Vaccine Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Covid-19 Vaccine Revenue and Market Share by Regions
4.2 North America Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
4.3 Europe Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
4.5 South America Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
5 North America Covid-19 Vaccine Revenue by Countries
5.1 North America Covid-19 Vaccine Revenue by Countries (2015-2020)
5.2 USA Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
5.3 Canada Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
5.4 Mexico Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
6 Europe Covid-19 Vaccine Revenue by Countries
6.1 Europe Covid-19 Vaccine Revenue by Countries (2015-2020)
6.2 Germany Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
6.3 UK Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
6.4 France Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
6.5 Russia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
6.6 Italy Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Covid-19 Vaccine Revenue by Countries
7.1 Asia-Pacific Covid-19 Vaccine Revenue by Countries (2015-2020)
7.2 China Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
7.3 Japan Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
7.4 Korea Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
7.5 India Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
8 South America Covid-19 Vaccine Revenue by Countries
8.1 South America Covid-19 Vaccine Revenue by Countries (2015-2020)
8.2 Brazil Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
8.3 Argentina Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Covid-19 Vaccine by Countries
9.1 Middle East & Africa Covid-19 Vaccine Revenue by Countries (2015-2020)
9.2 Saudi Arabia Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
9.3 UAE Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
9.4 Egypt Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
9.5 South Africa Covid-19 Vaccine Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Covid-19 Vaccine Revenue and Market Share by Type (2015-2020)
10.2 Global Covid-19 Vaccine Market Forecast by Type (2019-2024)
10.3 DNA Revenue Growth Rate (2015-2025)
10.4 Live Attenuated Virus Revenue Growth Rate (2015-2025)
10.5 NonReplicating Viral Vecto Revenue Growth Rate (2015-2025)
10.6 Protein Subunit Revenue Growth Rate (2015-2025)
10.7 RNA Revenue Growth Rate (2015-2025)
11 Global Covid-19 Vaccine Market Segment by Application
11.1 Global Covid-19 Vaccine Revenue Market Share by Application (2015-2020)
11.2 Covid-19 Vaccine Market Forecast by Application (2019-2024)
11.3 Treatment Revenue Growth (2015-2020)
11.4 Prevention Revenue Growth (2015-2020)
12 Global Covid-19 Vaccine Market Size Forecast (2021-2025)
12.1 Global Covid-19 Vaccine Market Size Forecast (2021-2025)
12.2 Global Covid-19 Vaccine Market Forecast by Regions (2021-2025)
12.3 North America Covid-19 Vaccine Revenue Market Forecast (2021-2025)
12.4 Europe Covid-19 Vaccine Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Covid-19 Vaccine Revenue Market Forecast (2021-2025)
12.6 South America Covid-19 Vaccine Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Covid-19 Vaccine Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
The report on the Global Tigecycline Market gives an estimation of the development of the market based on historical studies and also provides forecasts read more..
The Global Risperidone Market Report is equipped with market data from 2015 to 2025. The report gives a market overview covering key drivers and risks read more..
The report on the Global Caffeine Market gives an estimation of the development of the market based on historical studies and also provides forecasts on read more..
The report on the Global Rabies Vaccine Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Radiopharmaceuticals Market gives an estimation of the development of the market based on historical studies and also provides read more..
The report on the Global Neurorehabilitation System Market gives an estimation of the development of the market based on historical studies and also read more..
The report on the Global Molecular Biology Kits And Reagents Market gives an estimation of the development of the market based on historical studies and read more..
The report on the Global High Acuity Care Information Systems Market gives an estimation of the development of the market based on historical studies and read more..
The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013. A number of factors such as increasing bone related read more..
The report on the Global Skin Cancer Diagnostics Market gives an estimation of the development of the market based on historical studies and also read more..